Blogroll

Pages

lundi 11 janvier 2016

SportShire buys US drugs rival for $32bn

UK pharmaceutical firm Shire reaches a $32bn (£22bn) deal for US rival Baxalta to create rare-disease drugs giant.

from BBC News - US & Canada http://ift.tt/1Zgn1dO

0 commentaires:

Enregistrer un commentaire